BOEHRINGER INGELHEIM FDA Approval NDA 020291

NDA 020291

BOEHRINGER INGELHEIM

FDA Drug Application

Application #020291

Documents

Letter2009-05-13
Label2009-05-11
Letter2006-06-02
Letter2008-11-13
Letter2009-06-08
Letter2011-04-06
Letter2012-09-20
Letter2012-08-22
Label2006-06-02
Label2008-11-12
Label2009-06-04
Label2011-04-01
Label2012-08-20

Application Sponsors

NDA 020291BOEHRINGER INGELHEIM

Marketing Status

Discontinued001

Application Products

001AEROSOL, METERED;INHALATIONEQ 0.09MG BASE/INH;0.018MG/INH0COMBIVENTALBUTEROL SULFATE; IPRATROPIUM BROMIDE

FDA Submissions

TYPE 4; Type 4 - New CombinationORIG1AP1996-10-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1997-10-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1997-11-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1999-03-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1998-06-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1999-02-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1999-08-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1999-09-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP2001-07-23STANDARD
LABELING; LabelingSUPPL20AP2006-06-01STANDARD
LABELING; LabelingSUPPL23AP2008-11-10STANDARD
LABELING; LabelingSUPPL26AP2009-05-07STANDARD
LABELING; LabelingSUPPL27AP2009-06-02STANDARD
LABELING; LabelingSUPPL29AP2011-04-01UNKNOWN
LABELING; LabelingSUPPL30AP2012-09-17UNKNOWN
LABELING; LabelingSUPPL31AP2012-08-20UNKNOWN

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL9Null0
SUPPL11Null0
SUPPL12Null0
SUPPL29Null6
SUPPL30Null6
SUPPL31Null6

CDER Filings

BOEHRINGER INGELHEIM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20291
            [companyName] => BOEHRINGER INGELHEIM
            [docInserts] => ["",""]
            [products] => [{"drugName":"COMBIVENT","activeIngredients":"ALBUTEROL SULFATE; IPRATROPIUM BROMIDE","strength":"EQ 0.09MG BASE\/INH;0.018MG\/INH","dosageForm":"AEROSOL, METERED;INHALATION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"08\/20\/2012","submission":"SUPPL-31","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/020291s031lbl.pdf\"}]","notes":""},{"actionDate":"04\/01\/2011","submission":"SUPPL-29","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020291s029lbl.pdf\"}]","notes":""},{"actionDate":"06\/02\/2009","submission":"SUPPL-27","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020291s027lbl.pdf\"}]","notes":""},{"actionDate":"05\/07\/2009","submission":"SUPPL-26","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020291s026lbl.pdf\"}]","notes":""},{"actionDate":"11\/10\/2008","submission":"SUPPL-23","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/020291s023lbl.pdf\"}]","notes":""},{"actionDate":"06\/01\/2006","submission":"SUPPL-20","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020291s020lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"COMBIVENT","submission":"ALBUTEROL SULFATE; IPRATROPIUM BROMIDE","actionType":"EQ 0.09MG BASE\/INH;0.018MG\/INH","submissionClassification":"AEROSOL, METERED;INHALATION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2012-08-20
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.